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ess: n.pride@imperial.aSummary Progression of chronic obstructive pulmonary disease (COPD) has been
studied predominantly by following change in forced expiratory volume in 1 s (FEV1)
which reflects both primary airway disease and associated alveolar disease. Carbon
monoxide transfer (TLCO) (the product of the transfer coefficient KCO and alveolar
volume VA) is the only simple, widely available test of alveolar function, but few
studies have followed long-term changes in an individual.
Seventeen middle-aged men with moderate chronic airflow obstruction (mean
FEV1 56% of predicted values) were observed with yearly measurements of FEV1, TLCO
and KCO over a mean of 18.9 yr. At the end of follow-up FEV1 had fallen to 29% of
predicted values. VA, measured by single breath dilution, fell in each man. KCO at
recruitment ranged from 41% to 110% predicted and remained 475% predicted in
eight men at the end of follow-up supporting a phenotype of COPD with predominant
airway disease and little emphysema. Fall in FEV1 was faster (2.03% predicted FEV1/
yr) in seven men with low initial KCOo75% pred. than in men with initial KCO475%
pred. (1.14% predicted FEV1/yr, P ¼ 0:006).
Repeated measurements of CO transfer in an individual should increase the
present poor knowledge of the contribution of alveolar disease to the progression of
chronic airflow obstruction.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Progression of chronic obstructive pulmonary dis-
ease (COPD) has been studied predominantly by
following change in forced expiratory volume in 1 sElsevier Ltd. All rights reserv
8383 2350;
c.uk (N.B. Pride).(FEV1),
1–4 which is influenced both by primary
airway disease and associated alveolar disease
(emphysema). The respective roles of these two
components in determining progression probably
vary between individuals. Carbon monoxide trans-
fer (diffusing capacity) is the longest established
and simplest routine test of alveolar function, but
relatively little is known about the evolution of
changes in CO transfer in an individual over time ored.
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COPD. In this paper, we describe the long-term
evolution of values of CO transfer in 17 male
smokers or ex-smokers who were identified in
middle-age when they had moderate airflow ob-
struction and were subsequently observed for a
mean of 18.9 yr.Methods
Recruitment and follow-up of subjects
Meno65 yr old with moderate airways obstruction
(FEV1 40–80% of predicted value
5 with reduced
FEV1/VC ratio) which was apparently related to
smoking were recruited into a long-term follow-up
clinic. The men were detected during various
surveys of lung function conducted from this
hospital1,6 and were mainly office workers in West
London. Men with other significant conditions
affecting the natural history of lung function such
as post-tuberculous scarring, bronchiectasis, homo-
zygous a1-antitrypsin deficiency or men with an
overt history of past or present asthma were not
included in this analysis. All the remaining identi-
fied men who completed a minimum of 10 yr follow-
up are included in this report.
Men were followed at 4 monthly intervals; at
each of these visits a modified MRC questionnaire7
was applied, physical examination made, spirome-
try before and after bronchodilation with inhaled
b2-agonist and mixed venous Pco2 were measured
and any treatment checked. If necessary, visits
were postponed to avoid periods of acute exacer-
bation of disease or of potentially complicating
illness or procedures. Each year posterior–anterior
and lateral chest radiographs, electrocardiograms,
haemoglobin estimations and single breath carbon
monoxide transfer measurements were made.
Lung function
Forced expiratory volume in 1 s (FEV1) and slow
vital capacity (VC) were measured with a dry
spirometer. On each occasion the largest values
from three satisfactory measurements were taken.
Total lung capacity (TLC) was measured by whole
body plethysmography8 at recruitment only. Values
of spirometry and TLC were compared to EC
reference values.5
Carbon monoxide transfer factor (TLCO) was
measured by the single breath method.9 All details
of the method and analysis were unchanged
throughout the follow-up and correspond closelyto the current recommendations of the American
Thoracic Society10 and European Respiratory So-
ciety.5 Alveolar volume (VA) was calculated from
the single breath dilution of helium. The apparatus
and estimated anatomical dead space (VD anat)
were subtracted from the inspired volume, on the
assumption that VD anat ðmlÞ ¼ age ðyrÞ þweight
(lb) of each man. A correction was applied to the
expired gas concentrations to allow for absorption
of carbon dioxide (assumed to be 5%) from the
expired sample before its analysis. On each occa-
sion haemoglobin was measured and the TLCO
results were corrected to a standard haemoglobin
concentration of 14.3 g/l. No allowance was made
for the effect of carbon monoxide back pressure.
The mean value of 2 or 3 measurements with
appropriate inspired volume, breath-holding time
and an adequate alveolar sample5,10 at each visit
was used.
TLCO is the product of the subject’s VA expressed
at STPD and the rate constant (minutes1) for CO
uptake (kCO, the Krogh coefficient) divided by the
total gas pressure in the lungs (barometric pressure
Pb, minus water vapour pressure PH2O).
Tlco ¼ ðkco VaÞ=ðPb Ph2oÞ:
VA is measured at full inflation. In SI units TLCO is
expressed as mmol CO.min1 per pressure unit
which involves dividing VA ml STPD by 22.4.
The Krogh coefficient is now rarely employed;
instead the carbon monoxide transfer coefficient is
substituted whose SI units of mmol.min1 kPa1 l
(BTPS)1, give the appearance of being a ratio, an
impression sometimes enhanced by terminology
(TL/VA or DL/VA). In fact the CO transfer coefficient
in SI units equals kCO/2.56. To emphasize that the
primary measurement of CO transfer in the single
breath technique is the rate constant, we use the
unambiguous KCO as the abbreviation for the CO
transfer coefficient. VA was expressed in litres BTPS.
Values of TLCO and KCO were compared to reference
values obtained from West London subjects11 and
also to normal values reported from this labora-
tory.12 Mixed venous PCO2 was measured by the
rebreathing method.13Atopic status
Serum total IgE was measured by the PRIST
technique (Phadebas) and the results expressed as
the geometric mean. Prick skin tests to nine
common aeroallergens (Aspergillus fumigatus, Al-
ternaria, Cladosporium, grass pollen, cat and dog
dander, mixed feathers, wool and Dermatopha-
goides pteronyssinus) were performed on all men.
ARTICLE IN PRESS
Changes in CO transfer in COPD 1055Statistical analysis
For most analyses comparisons were of mean values
and changes between entry and final values;
difference between means was assessed by the
two-tail t-test (paired and unpaired) and statistical
significance was accepted at 0.05 level. The slope
of decline in FEV1 and in KCO in each individual was
expressed as a linear regression on age throughout
follow-up.Results
Clinical features of subjects at enrolment
and during follow-up (Table 1)
At recruitment 11 men were current smokers and
six were ex-smokers with a mean (SEM) of 35.1 (5.2)
pack-years. During follow-up, six of the remaining
smokers quit. Ten men had persistent chronic cough
and sputum production throughout follow-up. In
three men chronic cough and sputum resolved after
quitting smoking, and four denied perennial cough
or sputum production throughout.
Extensive efforts were made to detect asthmatic
features both at recruitment and during follow-up.
Prick skin tests to common aero-allergens were
negative in 16 men; the remaining man had a past
history of hay-fever and a positive prick skin test to
grass pollen (prick skin tests to other common aero-
allergens were all negative). Annual differential
white blood cell counts in venous blood showed no
eosinophilia. Total IgE results (available in 13 men)Table 1 Anthropometry and lung function at beginning
Entry
Mean (SEM)
Age yr 54.1 (1.4)
Height m 1.74 (0.02)
Weight kg 68.7 (3.0)
Follow-up yr 18.9 (1.1)
FEV1 Litres 1.90 (0.1)
% pred. 55.7 (2.5)
VC Litres 3.78 (0.2)
FEV1/VC % 51.3 (2.3)
TLCO SI units 7.92 (0.6)
% pred. 84.5 (7.2)
VA L BTPS 6.93 (0.3)
% pred. 102.7 (3.6)
KCO SI units 1.18 (0.1)
% pred. 73.9 (5.9)
SI units: TLCO, mmolmin1 kPa1 and KCO, mmolmin1 kPa1 l1.were in the normal range: geometric mean
32.2 ku l1.14 Most men ð1317Þ had negative elective
trials of oral prednisolone assessing changes in peak
expiratory flow and spirometry, sometimes on more
than one occasion. Two of the men at recruitment,
both with normal KCO values and normal chest
radiographs, had a bronchodilator response 410%
of predicted FEV1 (11.5% and 17.5%, respectively).
Both these men had two negative trials of oral
prednisolone and had no significant sputum eosino-
philia, but were treated throughout follow-up with
inhaled glucocorticosteroids (beclomethasone di-
propionate) despite these negative results. Four
other men had extended trials of this treatment
without benefit in spirometry or symptoms. None
were treated with long-term oral glucocorticoster-
oids, but bronchodilators were increasingly used
during follow-up as obstruction increased. Antibio-
tics were given as required for respiratory infec-
tions. Chest radiographs were assessed annually
(and initially blind to previous films) by an
experienced radiologist with particular experience
in the assessment of emphysema; at recruitment he
detected emphysema in four of the men which was
confirmed during annual follow-up. Possible em-
physema in a fifth man was noted less consistently.
Computed tomograms were not available in any of
these men. During follow-up five men developed
fatal carcinoma (two bronchial carcinoma, but with
considerable COPD also, two large bowel, one
prostate). In these patients the final follow-up data
presented were obtained before any complicating
lung disease developed. At the end of the follow-up
period 10 men were known to have died (five due to
carcinoma and five directly due to COPD), threeand end of follow-up in 17 men with COPD.
Final
Range Mean (SEM) Range
42–65
1.63–1.88
50–90 67.1 (3.3) 49–88
10–29
1.43–2.65 0.82 (0.09) 0.3–1.6
42–79 28.8 (2.9) 9–55
2.55–6.30 2.46 (0.19) 1.1–4.7
35.6–70.6 34.3 (3.2) 11–60
3.55–12.7 4.15 (0.5) 1.0–9.8
44–145 52.3 (6.9) 13–120
5.45–11.0 4.45 (0.3) 3.1–7.7
75–139 65.8 (3.0) 47–97
0.61–1.72 0.96 (0.1) 0.2–1.9
41–110 68.0 (8.7) 21–139
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follow-up. Only one man developed a raised mixed
venous PCO2 and this occurred in the last few
months before his death from COPD. None devel-
oped significant oedema, right-sided ECG changes0
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Figure 1 Relation between (a) TLCO and (b) TLCO%
predicted at beginning and end of follow-up in the 17
men.
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Figure 2 (a) Relation between (a) KCO and (b) KCO%
predicted at beginning and end of follow-up in the 17
men.
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Figure 3 Annual values of KCO (mmolmin1 kPa1 l1) for four
in SI units per year. (a) High normal value (110% predicted) at
(58% predicted) at entry but no consistent trend over subseq
entry with significant subsequent decline and (d) reduced va
decline.or marked enlargement of the heart on chest
radiographs.Lung function
Mean values of baseline spirometry and carbon
monoxide transfer are shown in Table 1. TLC was on
average 113% of the predicted value, with four men
having values greater than 130% predicted, VC was
88% of the predicted value. At entry there was a
wide range of individual values of TLCO (Fig. 1) and
KCO (Fig. 2), seven of the 17 men having initial
values of KCO less than 75% of predicted values.
These seven men included the five men with a
consistent or possible diagnosis of emphysema on
the chest radiograph.
Annual values of KCO in four representative men
are shown in Fig. 3. A significant decline in KCO on
age was found in only six of these men (see
examples Fig. 3c and d) which included five of the
seven men in whom KCO was o75% predicted at
entry. The final KCO was lower than entry KCO in 13
men (Fig. 2a), one man with a normal KCO at entry
showed a significant rise with time (Fig. 3a). To
summarize these results we have used entry and
final measurements of CO transfer in each man.
VA fell in every man as FEV1 deteriorated (Fig. 4),
the average fall being 35% from the initial value. As
a result absolute values of TLCO (Fig. 1a) and TLCO %
predicted (Fig. 1b) also fell during follow-up in
every man.0
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men plotted against each man’s age. Slopes are indicated
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uent years, (c) slightly reduced values (76% predicted) at
lue (40% predicted) at entry with significant subsequent
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Changes in CO transfer in COPD 1057At entry KCO was not significantly related to FEV1
(% predicted) or to FEV1/VC. We examined sub-
sequent annual decline in FEV1 in men with initial
KCO greater (n ¼ 10) and less than 75% predicted
(absolute value of KCOo1.03 SI units). Men with
initial KCOo75% predicted had lower weight and
body mass index (BMI: weight/height2) and a
slightly larger TLC (122% vs. 107% predicted,
P ¼ 0:154) but similar mean FEV1% predicted to
the group with higher initial KCO (Table 2 and Fig.
5). FEV1 fell faster (2.03% predicted FEV1 year
1) in
the men with initial values of KCO o75% pred. than
in men with initial KCO475% pred. (1.14% predicted
FEV1 year
1) ðP ¼ 0:006Þ: Absolute rates of FEV1
(ml yr) decline were also significantly different0.0 1.0
FEV1 (litres)
2.0 3.0
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Figure 4 Relation between absolute values of FEV1 and
VA at beginning (right hand points) and end of follow-up
(left-hand points) in the 17 men.
Table 2 Relation of initial KCO to patient characteristics
KCO% predict
Group A o75
Number 7
Age at entry 54.7 (5.3)
Years of follow-up 17.7 (1.5)
Entry
Weight kg 61.4 (3.3)
BMI kgm2 20.1 (0.9)
TLC litres 8.3 (0.77)
TLCO SI units 5.72 (0.57)
% pred. 59.4 (5.5)
VA litres 7.63 (0.64)
KCO SI units 0.78 (0.06)
% pred. 48.7 (3.5)
FEV1 % pred. 55.7 (3.8)
Decline in FEV1 ml yr
1 77 (9.3)
% pred. yr1 2.03 (0.27)
Mean (SEM) SI units: TLCO, mmolmin1 kPa1 and KCO, mmolminbetween the two groups ðP ¼ 0:011Þ: Decline of
FEV1 during follow-up in each individual was
inversely related to the initial values of KCO
expressed either as % predicted (r ¼ 0:592; P ¼
0:023) or as absolute values (r ¼ 0:539; P ¼ 0:025).
During follow-up the annual decline in KCO
averaged 0.16 SI units in the men whose initial
KCO waso75% predicted and 0.08 SI units in the
10 men whose initial KCO was475% predicted
(Table 2); the latter rate corresponded closely to
the predicted rate of decline in normal subjects.Discussion
We have examined the long-term evolution of CO
transfer in 17 middle-aged men, who were identi-
fied with moderate chronic airflow obstruction and
then followed for nearly two decades. We found an
initial wide spread of values of CO transfer
coefficient, which was sustained during follow-up.
Men with initially reduced values of CO transfer
coefficient had significantly faster subsequent
decline in FEV1.
Technical factors
The year-by-year variability in KCO was usually 0.2
SI units or less against an initial spread of values
in individual men which was more than 1.0 SI
units (Fig. 2a). A recent study of repeat KCO
measurements at a 7-day interval in patients withand changes in CO transfer and FEV1 during follow-up.
ed at entry
% pred. Group B 475% pred.
10
53.7 (6.2)
19.7 (1.6)
Final Entry Final
60.6 (4.5) 73.8 (3.8) 71.7 (4.1)
19.7 (1.0) 24.6 (1.0) 23.9 (1.1)
7.2 (0.33)
2.20 (0.30) 9.46 (0.58) 5.51 (0.54)
26.8 (3.7) 101.7 (7.7) 70.1 (7.2)
4.74 (0.57) 6.43 (0.21) 4.25 (0.20)
0.49 (0.07) 1.46 (0.05) 1.30 (0.10)
34.1 (5.0) 91.6 (3.9) 91.7 (8.0)
21.2 (3.0) 55.8 (3.4) 34.2 (3.7)
49 (4.7)
1.14 (0.14)
1 kPa1 l1.
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Figure 5 Relation of initial KCO (% predicted) to
subsequent decline in FEV1 Bars indicate SEM. The 17
men were divided into those with initial KCO o75%
predicted (group A, n ¼ 7) and475% predicted (group B,
n ¼ 10). Initial mean FEV1 (% predicted) was identical in
the two groups, but subsequent decline was greater in
group A (see text).
D.P. Osmanliev et al.1058emphysema found the coefficient of variability was
0.20 SI units.15
Originally VA during breathholding was calculated
as the sum of the inspired volume during the
manoeuvre and residual volume (RV) measured by
the helium multibreath dilution method16 (VA,mb).
Subsequently, VA has usually been estimated from
the dilution of helium or other insoluble marker gas
used in the procedure itself (VA,sb) so avoiding the
need for a separate measurement of RV. While
VA,mb and VA,sb are similar in normal subjects,
VA,sb underestimates VA,mb when there is airflow
obstruction.17 In the present study, VA,sb fell in all
subjects as airflow obstruction worsened (Fig. 4).
We did not obtain further values of TLC during
follow-up, but annual posterior–anterior and lat-
eral chest X-rays in each man showed no changes in
volume. Furthermore, as COPD progresses plethys-
mographic TLC either remains unchanged or slightly
increases.18
All measurements of TLCO,sb are obtained by
multiplying KCO times VA. Because changes in VA,sb
are so large in COPD we believe that changes in TLCO
cannot be interpreted without examining change in
KCO which is a better indication of alveolar
function. Our emphasis on KCO has been disputed,
as published fully elsewhere.19–21Generalizability of results
While observation of the present highly selected
group of men with airflow obstruction can illustrate
the varying patterns of change in CO transfer over
time, the present data cannot be used to estimatethe frequency of such patterns in the wider at-risk
population.Assessment of change in KCO and VA
Normal subjects
In normal subjects TLC does not change with age5
so that any true decline in TLCO is due to decline in
KCO. In cross-sectional studies the age coefficient
for KCO is consistently 0.01 SI units yr1 or less.22
Only a small study from our own laboratory has
reported longitudinal values over a similar period
to the present study;12 this study showed no change
in TLCO, VA,sb or KCO over 22 yr in middle-aged never
smoking men. These results sharply contrast with
two 8 yr follow-up studies which concluded that
TLCO declined at an accelerating rate with increas-
ing age with a much greater annual decline of
0.01623 or even 0.03524 SI units yr1 at 60 yr.COPD
Few previous studies have followed individuals with
regular measurements for sufficiently long periods
to describe the evolution from moderate-to-severe
airflow obstruction.25,26 During follow-up all 17
men had significant falls in FEV1, TLCO and VA,sb. A
fall in VA,sb can be a direct consequence of
emphysema replacing ventilated lung and reducing
VC, but also occurs with worsening gas mixing
consequent on uneven airway narrowing. Thus a fall
in TLCO is a much less specific indicator of alveolar
disease than KCO; indeed several of the present men
maintained a normal KCO throughout follow-up.
Among the men who had an initial KCO of o75%
predicted, the fastest individual rate of decline was
0.051 SI units yr1 in a man with radiological
evidence of emphysema. In contrast a 2 yr follow-
up of 43 men (mean age 52 yr) with severe a1-
antitrypsin deficiency has reported an average
annual decline of 0.04 SI units yr,27 four times the
normal change predicted by cross-sectional studies.
The mechanisms potentially reducing KCO in
emphysema are a reduction in alveolar wall surface
area-to-volume ratio (reflecting the increase in size
of the alveoli and breakdown of their walls)28 and/
or an irreversible reduction in pulmonary capillary
volume. Early clinico-pathological studies found an
inverse correlation of varying strength between
values of TLCO and KCO and the extent of macro-
scopic emphysema.29 Several mechanisms may
weaken this relationship. First, as already dis-
cussed, if VA,sb is used to calculate TLCO, TLCO may
be reduced by the development of airway disease
alone. It is not always clear whether VA,sb or VA,mb
has been used to calculate TLCO in the literature.
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little to the VC and the expired gas used for
measuring KCO, so any relation between CO transfer
and gross macroscopic emphysema presumably
depends on macroscopic emphysema being accom-
panied by microscopic emphysema in the remaining
functioning lung. Two studies have found pre-
operative KCO was strongly related to average
airspace size (i.e. microscopic emphysema) rather
than to macroscopic emphysema in surgical speci-
mens.30,31 Third, there is a fundamental difference
between the information provided by quantitative
pathology (or lung density, measured by computed
tomography, CT) which emphasizes the extent of
gross alveolar destruction, and by KCO, which
indicates the function in the remaining lung. Due
to the heterogeneity of disease the value of KCO will
inevitably be weighted by the ‘best’ remaining lung
which contributes most to the ventilated volume.
Indeed when the total pulmonary vascular bed is
greatly reduced, local blood flow in surviving
normal and near-normal areas of lung is increased
giving a ‘compensatory’ increase in local pulmon-
ary capillary volume and KCO. While KCO indicates
the ‘quality’ of the remaining lung, the total ability
of the lungs to take up oxygen depends on the
ventilated volume, a minimal estimate of which is
given by VA,sb. Even in those men whose KCO did not
change in follow-up, overall ability to take up
oxygen in the lung will have deteriorated due to
decline in VA,sb and this is correctly reflected in the
fall in TLCO.
In asthma, redistribution of cardiac output to
better ventilated areas of lung due to pulmonary
vasoconstriction in poorly ventilated areas, may
increase local pulmonary capillary volume and KCO,
and account for finding an above normal KCO value
as FEV1 falls in asthma.
32 The slow increase in KCO
over many years we observed in a man with
progressive airflow obstruction but apparently
normal alveolar function (Fig. 1a) might be caused
by similar changes in regional pulmonary capillary
volume.
Single measurements of TLCO in patients with
COPD have shown that a reduced value in early
disease is associated with accelerated decline in
FEV1,
33 and in advanced disease predicts exercise
capacity34 and influences mortality.35,36 In popula-
tion studies a reduced TLCO predicts all cause
mortality more strongly than a reduced FEV1.
37 At
present very little is known about the evolution of
changes in CO transfer and how it relates to change
in spirometry, although repeated measurements
are being made in recent studies of a1-antitrypsin
deficiency27 and its treatment.38 In cross-sectional
studies considerable reductions in CO transfer andlung recoil pressure have been described in
emphysema without much reduction in maximum
expiratory flow18,39,40 but the frequency of this
pattern is uncertain. The importance of emphyse-
ma in the genesis of airflow obstruction remains
surprisingly uncertain41,42 largely because of the
absence of longitudinal studies delineating the
alveolar and airway components.
In summary, we found considerable differences in
KCO among men with airways obstruction which
were sustained over many years, with some men
maintaining a near normal KCO, supporting earlier
concepts of a phenotype of COPD with predominant
chronic airway disease. Low KCO values predicted
COPD with particularly accelerated decline in FEV1.
Repeated measurements of CO transfer in an
individual are needed to increase the present poor
knowledge of the natural history of the contribu-
tion of alveolar disease to the progression of COPD.Acknowledgements
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